Pentagalloyl Glucose and Cisplatin Combination Treatment Exhibits a Synergistic Anticancer Effect in 2D and 3D Models of Head and Neck Carcinoma

Although cisplatin is a first-line chemotherapy drug for head and neck squamous cell carcinoma (HNSCC), its therapeutic efficacy is limited owing to serious side effects and acquired drug resistance. This study determined whether combining pentagalloyl glucose (PGG) and cisplatin enhanced their anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kantapan, Jiraporn, Intachai, Nuttawadee, Khamto, Nopawit, Meepowpan, Puttinan, Sangthong, Padchanee, Wantanajittikul, Kittichai, Dechsupa, Nathupakorn, Chitapanarux, Imjai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317773/
https://www.ncbi.nlm.nih.gov/pubmed/35890129
http://dx.doi.org/10.3390/ph15070830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317773/
https://www.ncbi.nlm.nih.gov/pubmed/35890129
http://dx.doi.org/10.3390/ph15070830

Ejemplares similares